Assessing the Effects of 0.3% Carboxymethylcellulose Tear Substitute Treatment on Symptoms and Signs of Dry Eye Disease in Elderly Population: A Prospective Longitudinal Study.
Antonio Ballesteros-SanchezJose María Sánchez-GonzálezGiovanni Roberto TedescoCarlos Rocha de LossadaGianluca MuranoAntonio SpinelliDavide BorroniPublished in: Journal of clinical medicine (2023)
0.3% CMC tear substitute treatment seems to achieve beneficial effects on the OSDI questionnaire, A-NIBUT, LLT, and ST. However, further studies at this concentration are needed to confirm these results.